Does expiratory flow limitation predict chronic dyspnoea in adults with cystic fibrosis?

European Respiratory Journal

Volumn 28, Issue 1, 2006, Pages 96-101

  Holland, A E ^a,b   Denehy, L ^b   Wilson, J W ^a,c  

^a ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Cystic fibrosis; Dyspnoea; Respiratory function tests

Indexed keywords

ADULT; AGE; ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE ASSOCIATION; DYSPNEA; EXPIRATORY FLOW; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HYPERINFLATION; INSPIRATORY CAPACITY; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RATING SCALE; REGRESSION ANALYSIS; SITTING; SPIROMETRY; SUPINE POSITION; TIDAL VOLUME;

ADULT; CASE-CONTROL STUDIES; CYSTIC FIBROSIS; DYSPNEA; FEMALE; FORCED EXPIRATORY FLOW RATES; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; MALE; RESPIRATION; RESPIRATORY FUNCTION TESTS; SPIROMETRY;

EID: 33845508816     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.06.00122105     Document Type: Article

References (26)

1. Tantucci C, Duguet A, Similowski T, Zelter M, Derenne JP, Milic-Emil J. Effect of salbutamol on dynamic pulmonary hyperinflation in chronic obstructive lung disease patients. Eur Respir J 1998; 12: 799-804.
2. Bellemare F, Grassino A. Force reserve of the diaphragm in patients with chronic obstructive pulmonary disease. J Appl Physiol 1983; 55: 8-15.
3. Coussa ML, Guerin C, Eissa NT, et al. Partitioning of work of breathing in mechanically ventilated COPD patients. J Appl Physiol 1993; 75: 1711-1719.
4. Eltayara L, Becklake MR, Volta CA, Milic-Emili J. Relationship between chronic dyspnea and expiratory flow limitation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996;154: 1726-1734.
5. Goetghebeur D, Sarni D, Grossi Y, et al. Tidal expiratory flow limitation and chronic dyspnoea in patients with cystic fibrosis. Eur Respir J 2002; 19: 492-498.
6. Braggion C, Polese G, Fenzi V, Carli MV, Pradal U, Milic-Emili J. Detection of tidal expiratory flow limitation in infants with cystic fibrosis: a pilot study. Pediatr Pulmonol 1998; 25: 213-215.
7. Tauber E, Fazekas T, Eichler I, et al. Negative expiratory pressure: a new tool for evaluating lung function in children? Pediatr Pulmonol 2003; 35: 162-168.
8. Erwin WS, Zolov D, Bickerman HA. The effect of posture on respiratory function in patients with obstructive pulmonary emphysema. Am Rev Respir Dis 1966; 94: 865-872.
9. Regnis JA, Alison JA, Henke KG, Donnelly PM, Bye PT. Changes in end-expiratory lung volume during exercise in cystic fibrosis relate to severity of lung disease. Am Rev Respir Dis 1991; 144: 507-512.
10. van der Schans CP. Forced expiratory manoeuvres to increase transport of bronchial mucus: a mechanistic approach. Monaldi Arch Chest Dis 1997; 52: 367-370.
11. Cooper PJ, Robertson CF, Hudson IL, Phelan PD. Variability of pulmonary function tests in cystic fibrosis. Pediatr Pulmonol 1990; 8: 16-22.
12. Koulouris NG, Volta P, Lavoie A, et al. A simple method to detect expiratory flow limitation during spontaneous breathing. Eur Respir J 1995; 8: 306-313.
13. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993; 6: Suppl. 6, 5-40.
14. American Thoracic Society. Standardization of spirometry, 1994 update. American Thoracic Society. Am J Respir Crit Care Med 1995; 152: 1107-1136.
15. Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983; 127: 725-734.
16. McCullach P. Regression models for ordinal data (with discussion). J R Stat Soc 1980; Series B: 109-142.
17. Portney L, Watkins M. Foundations of Clinical Research: Applications to Practice: 2nd Edn. Appleton and Lange, Connecticut, 1993; pp. 505-527.
18. Ries AL, Sosa G, Prewitt L, Friedman PJ, Harwood IR. Restricted pulmonary function in cystic fibrosis. Chest 1988; 94: 575-579.
19. de Jong W, van der Schans CP, Mannes GP, van Aalderen WM, Grevink RG, Koeter GH. Relationship between dyspnoea, pulmonary function and exercise capacity inpatients with cystic fibrosis. Respir Med 1997; 91:41-116.
20. Chetta A, Pisi G, Zanini A, et al. Six-minute walking test in cystic fibrosis adults with mild to moderate lung disease: comparison to healthy subjects. Respir Med 2001; 95: 986-991.
21. Killian KJ, Summers E, Jones NL, Campbell EJ. Dyspnea and leg effort during incremental cycle ergometry. Am Rev Respir Dis 1992; 145: 1339-1345.
22. Yankaskas JR, Marshall BC, Sufian B, Simon RH, Rodman D. Cystic fibrosis adult care: consensus conference report. Chest 2004; 125: 1S-39S.
23. Regnis JA, Donnelly PM, Robinson M, Alison JA, Bye PT. Ventilatory mechanics at rest and during exercise in patients with cystic fibrosis. Am J Respir Crit Care Med 1996; 154: 1418-1425.
24. Fauroux B, Boule M, Lofaso F, et al. Chest physiotherapy in cystic fibrosis: improved tolerance with nasal pressure support ventilation. Pediatrics 1999; 103: 1-9.
25. Smith TC, Marini JJ. Impact of PEEP on lung mechanics and work of breathing in severe airflow obstruction. J Appl Physiol 1988; 65: 1488-1499.
26. Henke KG, Regnis JA, Bye PT. Benefits of continuous positive airway pressure during exercise in cystic fibrosis and relationship to disease severity. Am Rev Respir Dis 1993; 148: 1272-1276.